Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 2 Trials for Etanercept (DB00005)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00141726Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell TransplantTreatment